Abstract General Information

Título / Title

A PILOT STUDY OF INTRAOPERATIVE MELPHALAN TO PREVENT RECURRENT PVR: THE IOMPVR STUDY

Introdução / Purpose

To evaluate the safety and efficacy of 5 μg/0.1 ml intravitreal melphalan at the end of pars plana vitrectomy (PPV) before silicone oil (SO) injection in eyes with primary PVR related to rhegmatogenous retinal detachments (RRDs)

Material e Método / Methods

Prospective, cross-sectional, interventional pilot study in patients with primary RRD and PVR. Six patients were included who were aged 18 to 85 years with PVR grade CP2 or worse secondary to RRDs in eyes without having undergone a previous RRD surgery. The patients underwent PPV + scleral buckle + fluid air exchange followed by intravitreal injection of 5 μg/0.1 ml melphalan (270 mOsm) and SO injection. The follow-up period was minimal of 90 days

Resultados / Results

Six eyes of six patients were enrolled. Ocular examination and imaging showed no retinal toxicity. The logarithm of the minimum angle of resolution best-corrected visual acuity improved from the mean ± standard deviation preoperatively of 2.11 ± 0.22 to 0.89 ± 0.37 at 30 and to 0.84 ± 0.42 at 90 days postoperative (P<0.001). Optical coherence tomography identified intraretinal cysts in five of six eyes and outer retinal layer loss in all eyes. Only one of six eyes developed a recurrent localized RD on day 90 unrelated to recurrent PVR. PVR recurrence was not observed during the study follow-up

Discussão e Conclusões / Conclusion

In this pilot study, the preliminary data showed that PPV followed by intravitreal injection of 5 μg/0.1 ml melphalan was not related to ocular toxicity. The absence of PVR recurrence at 3 months follow-up in these complex PVR eyes is an interesting finding that justifies further investigation

Palavras Chave

Melphalan, Pars plana vitrectomy, Proliferative vitreoretinopathy, Retinal detachment